Please Wait.....
Report
Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 253 Pages I Data Bridge Market Research
The Europe thyroid cancer diagnostics market is projected to register a substantial CAGR of 5.2% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030
Market Segmentation:
Europe Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and the Rest of Europe) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Europe thyroid cancer diagnostics market are:
- Rising incidence and prevalence of thyroid nodules & cancer
- Rising thyroid cancer diagnostic tests rise in product approvals
- Rise in healthcare expenditure for cancer diagnosis and treatment
Market Players:
Some of the major players operating in the Europe thyroid cancer diagnostics market are:
- FUJIFILM Holdings Corporation
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated
- Illumina
- Koninklijke Philips N.V.
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- Abbott
- General Electric Company
- BD
- QIAGEN
- DIASORIN S.P.A.
- Merck KGaA
- Hologic
- Myriad Genetics Inc.
- BIOMERIEUX
- FONAR Corp.
- MinFound Medical Systems Co., Ltd
- Medonica Co. LTD
TABLE OF CONTENTS
1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE EUROPE THYROID CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48
2 MARKET SEGMENTATION 51
2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET TESTING TYPE COVERAGE GRID 61
2.11 VENDOR SHARE ANALYSIS 62
2.12 SECONDARY SOURCES 63
2.13 ASSUMPTIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 67
4.1 PESTEL ANALYSIS 68
4.2 PORTER'S FIVE FORCES 69
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 70
5 EPIDEMIOLOGY 71
6 REGULATORY FRAMEWORK OF THE EUROPE THYROID CANCER DIAGNOSTICS MARKET 72
6.1 REGULATORY SCENARIO IN THE U.S. 72
6.2 REGULATORY SCENARIO IN AUSTRALIA 73
6.3 REGULATORY SCENARIO IN JAPAN 73
6.4 REGULATORY SCENARIO IN CHINA 73
7 MARKET OVERVIEW 74
7.1 DRIVERS 76
7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 76
7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 76
7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 77
7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 77
7.2 RESTRAINTS 78
7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 78
7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 79
7.3 OPPORTUNITIES 79
7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 79
7.3.2 RISING OBESE POPULATION 80
7.4 CHALLENGES 80
7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 80
7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 81
8 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 82
8.1 OVERVIEW 83
8.2 INSTRUMENTS 86
8.2.1 PATHOLOGY BASED INSTRUMENTS 87
8.2.1.1 PCR INSTRUMENTS 87
8.2.1.2 SLIDE STAINING SYSTEMS 87
8.2.1.3 TISSUE PROCESSING SYSTEMS 87
8.2.1.4 CELL PROCESSORS 88
8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 88
8.2.2 IMAGING INSTRUMENTS 88
8.2.2.1 ULTRASOUND SYSTEMS 88
8.2.2.2 CT SYSTEMS 88
8.2.2.3 MRI SYSTEMS 88
8.2.2.4 OTHERS 88
8.2.3 BIOPSY INSTRUMENTS 89
8.2.3.1 NEEDLE BIOPSY 89
8.2.3.2 ENDOSCOPIC BIOPSY 89
8.2.3.3 CORE BIOPSY 89
8.2.3.4 OTHERS 89
8.2.4 OTHERS 89
8.3 CONSUMABLES & ACCESSORIES 90
8.3.1 KITS 91
8.3.1.1 PCR KITS 91
8.3.1.2 DNA POLYMERASE KITS 91
8.3.1.3 NUCLEIC ACID ISOLATION KITS 91
8.3.1.4 OTHERS 91
8.3.2 REAGENTS 92
8.3.2.1 ASSAYS 92
8.3.2.2 BUFFERS 92
8.3.2.3 PRIMERS 92
8.3.2.4 OTHERS 92
8.3.3 PROBES 92
8.3.4 OTHER CONSUMABLES 92
9 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 93
9.1 OVERVIEW 94
9.2 IMAGING TEST 97
9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
9.2.2 MRI 98
9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 98
9.2.4 OTHERS 98
9.3 BLOOD TEST 99
9.3.1 BLOOD CHEMISTRY TESTS 100
9.3.2 COMPLETE BLOOD COUNT (CBC) 100
9.3.3 OTHERS 100
9.4 BIOPSY 100
9.4.1 NEEDLE BIOPSY 101
9.4.2 BRONCHOSCOPY BIOPSY 101
9.4.3 CORE BIOPSY 101
9.4.4 OTHERS 101
9.5 OTHERS 102
10 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 103
10.1 OVERVIEW 104
10.2 PAPILLARY CARCINOMA 107
10.3 FOLLICULAR CARCINOMA 108
10.4 OTHERS 109
11 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 110
11.1 OVERVIEW 111
11.2 STAGE I 114
11.3 STAGE II 115
11.4 STAGE III 116
11.5 STAGE IV 117
12 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 118
12.1 OVERVIEW 119
12.2 30-65 122
12.3 65 AND ABOVE 123
12.4 21-29 124
12.5 BELOW 21 125
13 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY END USER 126
13.1 OVERVIEW 127
13.2 HOSPITALS 130
13.3 ASSOCIATED LABS 131
13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
13.5 DIAGNOSTIC IMAGING CENTERS 132
13.6 CANCER RESEARCH INSTITUTES 133
13.7 OTHERS 134
14 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135
14.1 OVERVIEW 136
14.2 DIRECT TENDER 139
14.3 RETAIL SALES 140
15 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY REGION 141
15.1 EUROPE 142
15.1.1 GERMANY 152
15.1.2 U.K. 157
15.1.3 ITALY 162
15.1.4 FRANCE 167
15.1.5 SPAIN 172
15.1.6 RUSSIA 177
15.1.7 SWITZERLAND 182
15.1.8 TURKEY 187
15.1.9 BELGIUM 192
15.1.10 NETHERLANDS 197
15.1.11 REST OF EUROPE 202
16 EUROPE THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 203
16.1 COMPANY SHARE ANALYSIS: EUROPE 203
17 SWOT ANALYSIS 204
18 COMPANY PROFILE 205
18.1 CANON INC. 205
18.1.1 COMPANY SNAPSHOT 205
18.1.2 COMPANY SHARE ANALYSIS 205
18.1.3 PRODUCT PORTFOLIO 206
18.1.4 RECENT DEVELOPMENTS 206
18.2 FUJIFILM CORPORATION 207
18.2.1 COMPANY SNAPSHOT 207
18.2.2 REVENUE ANALYSIS 207
18.2.3 COMPANY SHARE ANALYSIS 208
18.2.4 PRODUCT PORTFOLIO 208
18.2.5 RECENT DEVELOPMENT 208
18.3 F. HOFFMANN-LA ROCHE LTD 209
18.3.1 COMPANY SNAPSHOT 209
18.3.2 REVENUE ANALYSIS 209
18.3.3 COMPANY SHARE ANALYSIS 210
18.3.4 PRODUCT PORTFOLIO 210
18.3.5 RECENT DEVELOPMENT 210
18.4 QUEST DIAGNOSTICS INCORPORATED 211
18.4.1 COMPANY SNAPSHOT 211
18.4.2 REVENUE ANALYSIS 211
18.4.3 COMPANY SHARE ANALYSIS 212
18.4.4 PRODUCT PORTFOLIO 212
18.4.5 RECENT DEVELOPMENTS 212
18.5 ILLUMINA, INC. 214
18.5.1 COMPANY SNAPSHOT 214
18.5.2 REVENUE ANALYSIS 214
18.5.3 COMPANY SHARE ANALYSIS 215
18.5.4 PRODUCT PORTFOLIO 215
18.5.5 RECENT DEVELOPMENT 215
18.6 ABBOTT 216
18.6.1 COMPANY SNAPSHOT 216
18.6.2 REVENUE ANALYSIS 216
18.6.3 PRODUCT PORTFOLIO 217
18.6.4 RECENT DEVELOPMENT 217
18.7 BD 218
18.7.1 COMPANY SNAPSHOT 218
18.7.2 REVENUE ANALYSIS 218
18.7.3 PRODUCT PORTFOLIO 219
18.7.4 RECENT DEVELOPMENT 219
18.8 BEIJING O&D BIOTECH CO., LTD. 220
18.8.1 COMPANY SNAPSHOT 220
18.8.2 PRODUCT PORTFOLIO 220
18.8.3 RECENT DEVELOPMENTS 220
18.9 BIOMERIEUX SA 221
18.9.1 COMPANY SNAPSHOT 221
18.9.2 REVENUE ANALYSIS 221
18.9.3 PRODUCT PORTFOLIO 222
18.9.4 RECENT DEVELOPMENTS 222
18.10 DIASORIN S.P.A. 223
18.10.1 COMPANY SNAPSHOT 223
18.10.2 REVENUE ANALYSIS 223
18.10.3 PRODUCT PORTFOLIO 224
18.10.4 RECENT DEVELOPMENT 224
18.11 FONAR CORP. 225
18.11.1 COMPANY SNAPSHOT 225
18.11.2 REVENUE ANALYSIS 225
18.11.3 PRODUCT PORTFOLIO 226
18.11.4 RECENT DEVELOPMENTS 226
18.12 GENERAL ELECTRIC 227
18.12.1 COMPANY SNAPSHOT 227
18.12.2 REVENUE ANALYSIS 227
18.12.3 PRODUCT PORTFOLIO 228
18.12.4 RECENT DEVELOPMENTS 228
18.13 HOLOGIC INC. 229
18.13.1 COMPANY SNAPSHOT 229
18.13.2 REVENUE ANALYSIS 229
18.13.3 PRODUCT PORTFOLIO 230
18.13.4 RECENT DEVELOPMENT 230
18.14 KONINKLIJKE PHILIPS N.V. 231
18.14.1 COMPANY SNAPSHOT 231
18.14.2 REVENUE ANALYSIS 231
18.14.3 PRODUCT PORTFOLIO 232
18.14.4 RECENT DEVELOPMENT 232
18.15 MERCK KGAA. 233
18.15.1 COMPANY SNAPSHOT 233
18.15.2 REVENUE ANALYSIS 233
18.15.3 PRODUCT PORTFOLIO 234
18.15.4 RECENT DEVELOPMENT 234
18.16 MEDONICA CO. LTD 235
18.16.1 COMPANY SNAPSHOT 235
18.16.2 PRODUCT PORTFOLIO 235
18.16.3 RECENT DEVELOPMENT 235
18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 236
18.17.1 COMPANY SNAPSHOT 236
18.17.2 PRODUCT PORTFOLIO 236
18.17.3 RECENT DEVELOPMENTS 237
18.18 MYRIAD GENETICS, INC. 238
18.18.1 COMPANY SNAPSHOT 238
18.18.2 REVENUE ANALYSIS 238
18.18.3 PRODUCT PORTFOLIO 239
18.18.4 RECENT DEVELOPMENTS 239
18.19 PLEXBIO. 240
18.19.1 COMPANY SNAPSHOT 240
18.19.2 PRODUCT PORTFOLIO 240
18.19.3 RECENT DEVELOPMENTS 240
18.20 QIAGEN 241
18.20.1 COMPANY SNAPSHOT 241
18.20.2 REVENUE ANALYSIS 241
18.20.3 PRODUCT PORTFOLIO 242
18.20.4 RECENT DEVELOPMENT 242
18.21 STERNMED GMBH 243
18.21.1 COMPANY SNAPSHOT 243
18.21.2 PRODUCT PORTFOLIO 243
18.21.3 RECENT DEVELOPMENTS 243
18.22 SIEMENS HEALTHCARE GMBH 244
18.22.1 COMPANY SNAPSHOT 244
18.22.2 REVENUE ANALYSIS 244
18.22.3 PRODUCT PORTFOLIO 245
18.22.4 RECENT DEVELOPMENT 245
18.23 TIME MEDICAL HOLDING. 246
18.23.1 COMPANY SNAPSHOT 246
18.23.2 PRODUCT PORTFOLIO 246
18.23.3 RECENT DEVELOPMENT 246
18.24 THERMO FISHER SCIENTIFIC INC. 247
18.24.1 COMPANY SNAPSHOT 247
18.24.2 REVENUE ANALYSIS 247
18.24.3 PRODUCT PORTFOLIO 248
18.24.4 RECENT DEVELOPMENT 248
19 QUESTIONNAIRE 249
20 RELATED REPORTS 253
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security